Itaconix Achieves Record Half-Year Revenues and Expands Product Offerings

An update from Itaconix ( (GB:ITX) ) is now available.

Itaconix plc reported record half-year revenues of $4.8 million for the period ending June 30, 2025, marking a significant milestone in establishing its products as core ingredients in sustainable consumer products. The company has launched BIO*Asterix® and expanded its SPARX™ collaborations, resulting in three distinct revenue streams. Itaconix has also extended its partnership with Croda and mitigated international trade risks, while investing in marketing and supply chain resilience. With a strong balance sheet and a growing pipeline of opportunities, Itaconix is well-positioned for sustained growth and long-term shareholder value.

The most recent analyst rating on (GB:ITX) stock is a Buy with a £325.00 price target. To see the full list of analyst forecasts on Itaconix stock, see the GB:ITX Stock Forecast page.

Spark’s Take on GB:ITX Stock

According to Spark, TipRanks’ AI Analyst, GB:ITX is a Neutral.

Itaconix faces significant profitability and cash flow challenges despite revenue growth and a strong equity base. Technical indicators show bearish trends, and valuation metrics are weak. However, strategic initiatives and product innovations offer a positive future outlook, slightly boosting the overall score.

To see Spark’s full report on GB:ITX stock, click here.

More about Itaconix

Itaconix plc is a leading innovator in sustainable plant-based polymers, focusing on improving the safety, performance, and environmental profile of consumer and industrial products. The company leverages itaconic acid to produce high-performance materials across multiple markets, aiming to replace fossil-based chemicals in applications such as detergents, paints, and coatings.

Average Trading Volume: 7,969

Technical Sentiment Signal: Sell

Current Market Cap: £17.53M

Find detailed analytics on ITX stock on TipRanks’ Stock Analysis page.